AZR-MD-001 Vehicle

DRUG3 trials

Sponsors

Azura Ophthalmics

Conditions

Contact Lens Discomfort (CLD)Dry EyeMeibomian Gland DysfunctionMeibomian Gland Dysfunction (MGD)

Phase 2

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

CompletedNCT03652051

Azura OphthalmicsDry Eye, Meibomian Gland Dysfunction

Start: 2018-09-10End: 2022-10-19Updated: 2024-02-28

An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)

CompletedNCT03972501

Azura OphthalmicsContact Lens Discomfort (CLD), Meibomian Gland Dysfunction (MGD)

Start: 2019-10-04End: 2020-12-11Updated: 2023-01-25

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

CompletedNCT04391959

Azura OphthalmicsMeibomian Gland Dysfunction

Start: 2020-07-17End: 2021-01-06Updated: 2022-05-16

Related Papers

Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial.

2023-07-2015 citations